The High-Tech Agenda Needs a Catalytic Moment for Biomedical Innovation

Bioengineering IBMI March 9, 2026

In a joint guest article published in Table.Media, bioengineering expert Vasilis Ntziachristos and deep-tech specialist Francis de Véricourt examine the key levers needed to sustainably advance biomedical innovation in Germany and Europe. The two researchers call for a “Whitaker moment” for Germany’s biotechnology innovation and the medicine of tomorrow, citing the investments of the namesake foundation in the U.S. as a model.

For more see German Version.

Published January, 2026 on Table.Media

Prof. Dr. Vasilis Ntziachristos

Direktor des Instituts für Biologische und Medizinische Bildgebung, Direktor des Bioengineering Centers

View profile

Biomedical engineering applies engineering principles to address challenges in medicine and biology. To explore ways of strengthening biomedical engineering as a driver of innovation and growth in Europe, EMBO and the Helmholtz Bioengineering…

Helmholtz Biomedical Engineering Initiative

The Helmholtz Association is launching a nationwide biomedical engineering initiative to accelerate technology development and transfer activities. Led by its established Health Centers, “Helmholtz Biomedical Engineering” brings together cutting-edge…

A dynamic web of entities and people working together to foster and advance new ideas, technologies, and solutions.

Helmholtz Munich is partnering with Deep Science Ventures (DSV) and SPRIND, Germany’s Federal Agency for Disruptive Innovation, to support the Venture Science Doctorate (VSD) – a novel doctoral program designed to train scientists to build…

Share Share Share Mail

The High-Tech Agenda Needs a Catalytic Moment for Biomedical Innovation

Related news

Biomedical Engineering: Science Translation for Future Health

Helmholtz Biomedical Engineering Initiative: Shaping the Future of Health

From Lab Bench to Startup: New Doctorate Program Offers Scientists a Venture-Building Path